Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage-colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses

Blood

Volumn 96, Issue 4, 2000, Pages 1317-1326

  Stripecke, R ^a   Cardoso, A A ^a   Pepper, K A ^a   Skelton, D C ^a   Yu, X J ^a   Mascarenhas, L ^a   Weinberg, K I ^a   Nadler, L M ^a   Kohn, D B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CYTOKINE; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; MESSENGER RNA; MONOCLONAL ANTIBODY; VIRUS PROTEIN; VIRUS VECTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LENTIVIRINAE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0034663189     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.4.1317.h8001317_1317_1326     Document Type: Article

References (47)

1. Human tumor antigens recognized by T lymphocytes
2. Novel costimulators in the immune gene therapy of cancer
3. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin-2 mRNA accumulation
4. Expression of costimulatory molecules in human leukemias
5. Pre-B acute lymphoblastic leukemia cells may induce T-cell energy to alloantigen
6. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen presenting cells
7. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long lasting anti-tumor immunity
8. Immune response to Philadelphia chromosome positive acute lymphoblastic leukemia induced by coexpression of CD80, GM-CSF and IL-2
9. Combination of CD80 and GM-CSF co-expression by a leukemia cell vaccine: Pre-clinical studies in a murine model recapitulating Philadelphia chromosome positive acute lymphoblastic leukemia
10. Gene delivery to human precursor acute lymphoblastic leukemia cells
11. Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1
12. A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cells
13. Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): Delivery to acute myeloid leukemic blasts using adeno-associated virus
14. CD80-transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens
15. - human hematopoietic cells by HIV-1-based lentiviral vectors
16. Productive human immunodeficiency virus type 1 (HIV-1) infection of non-proliferating human monocytes
17. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
18. Proliferation of precursor B-lineage acute lymphoblastic leukemia by activating the CD40 antigen
19. Efficient transfer, integration and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
20. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
21. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells
22. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting lymphocytes
23. The plC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation
24. Human GM-CSF molecular cloning of the complementary DNA and purification of the natural and recombinant proteins
25. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
26. Cancer vaccines; the interleukin 2 dosage effect
27. Enhanced immune priming with spatial distribution of paracrine cytokine vaccines
28. Self-inactivating lentiviral vector for safe and efficient in vivo gene delivery
29. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
30. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
31. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells
32. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated forms of major histocompatibility complex class II molecules
33. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: An important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells
34. Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules
35. Major histocompatibility complex class II+ B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice
36. Role of B7-1 in mediating an immune response to myeloid leukemia cells
37. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity
38. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors
39. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity
40. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum
41. Clinical protocol: A phase I study of vaccination with autologous irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor
42. Clinical protocol: A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma
43. Clinical proto col: Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma
44. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma
45. IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL)
46. A third generation lentiviral vector with a conditional packaging system
47. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells